ArticleRenal failure2026
Four-organ SOFA score as a potential tool to triage use of continuous kidney replacement therapy in COVID-19 patients with acute kidney injury: a retrospective two-center study.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lessons learned: management of acute kidney injury during COVID-19.Renal failure · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury requiring continuous kidney replacement therapy (AKI-CKRT) in the setting of coronavirus disease 2019 (COVID-19) carries a high mortality. In this two-center retrospective cohort study, we analyzed whether a simplified Sequential Organ Failure Assessment (SOFA) score, the 4-organ SOFA score with renal and neurologic sub-scores removed, would perform as well as the full SOFA score in predicting mortality. In our primary cohort, we identified 63 patients with COVID-19 hospitalized in April 2020 to July 2021 with AKI-CKRT and determined their 4-organ and full SOFA scores at CKRT initiation. Thirty-day and in-hospital mortality were 73.0% and 82.5%, respectively. The median 4-organ SOFA score at CKRT initiation among 30-day survivors was 7 (interquartile range 5.5-8.5) versus 8 (7-10) among 30-day non-survivors (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.